Valley National Advisers’s West Pharmaceutical WST Stock Holding History

Valley National Advisers’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08K	Buy	+3	New	+$917	﹤0.01%	871
2024 Q3	–	Sell	-6	Closed	-$1K	–	1158
2024 Q2	$1K	Buy	6 +1	+20%	+$353	﹤0.01%	1149
2024 Q1	$1K	Sell	5 -5	-50%	-$1.85K	﹤0.01%	1197
2023 Q4	$3K	Sell	10 -2	-17%	-$708	﹤0.01%	905
2023 Q3	$5K	Buy	12 +8	+200%	+$3.09K	﹤0.01%	715
2023 Q2	$2K	Buy	+4	New	+$1.43K	﹤0.01%	832

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Valley National Advisers's WST Position: Q2 2026 in Review

Valley National Advisers opened a new position in West Pharmaceutical (WST) in Q2 2026: 3 shares worth $1.08K. The stake represents ﹤0.01% of the portfolio and ranks #871 among its holdings. This is a return to the name: Valley National Advisers previously reported a position in WST as recently as Q2 2024.

Valley National Advisers first reported a position in WST in Q2 2023 and has held it in 6 quarters since. The position peaked at $5K in Q3 2023. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Valley National Advisers held 3 shares of West Pharmaceutical worth $1.08K as of Q2 2026.
West Pharmaceutical was a new Valley National Advisers position in Q2 2026.
West Pharmaceutical made up ﹤0.01% of Valley National Advisers's portfolio in Q2 2026, its #871 holding.
Valley National Advisers first reported a position in West Pharmaceutical in Q2 2023 and has held it in 6 quarters since.
Valley National Advisers's West Pharmaceutical position peaked at $5K in Q3 2023.
832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Valley National Advisers's 13F filing for Q2 2026, filed 29 Jul 2026.